3.24
-0.13(-3.86%)
Currency In USD
| Previous Close | 3.37 |
| Open | 3.37 |
| Day High | 3.41 |
| Day Low | 3.21 |
| 52-Week High | 10.48 |
| 52-Week Low | 1.6 |
| Volume | 263,260 |
| Average Volume | 357,950 |
| Market Cap | 125M |
| PE | -1.49 |
| EPS | -2.17 |
| Moving Average 50 Days | 3.98 |
| Moving Average 200 Days | 3.38 |
| Change | -0.13 |
If you invested $1000 in Protara Therapeutics, Inc. (TARA) 10 years ago, it would be worth $5.02 as of May 10, 2025 at a share price of $3.24. Whereas If you bought $1000 worth of Protara Therapeutics, Inc. (TARA) shares 5 years ago, it would be worth $128.57 as of May 10, 2025 at a share price of $3.24.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
May 01, 2025 8:09 PM GMT
NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the recen
Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC
GlobeNewswire Inc.
Apr 26, 2025 2:00 PM GMT
TARA-002 demonstrates 100% complete response rate at any time and 67% 12-month landmark complete response rate in BCG-Unresponsive patientsTARA-002 demonstrates 76% complete response rate at any time and 43% 12-month landmark complete response rate i
Protara Therapeutics to Host Conference Call and Webcast to Review Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC on Monday, April 28, 2025
GlobeNewswire Inc.
Apr 23, 2025 12:00 PM GMT
NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced it will host a conference call and l